| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SLGC | Class A Common Stock | Award | +215K | +2.17% | 10.1M | Sep 29, 2022 | See footnote | F1, F2 |
| Id | Content |
|---|---|
| F1 | In connection with the closing (the "Closing") of the business combination (the "Business Combination") between the Issuer and Palamedrix, Inc., the selling shareholders collectively received (i) 4,030,472 shares of Common Stock and (ii) 5,578,388 shares of Common Stock which may be issuable upon the achievement of certain milestones. The forgoing description of the Business Combination does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's S-3 filed on October 31, 2022, which is incorporated by reference. |
| F2 | The securities are owned directly by Casdin Partners Master Fund, LP (the "Master Fund") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC, the investment adviser to the Master Fund, (ii) Casdin Partners GP, LLC, the general partner of the Master Fund, and (iii) Eli Casdin, the managing member of Casdin Capital, LLC and Casdin Partners GP, LLC. |
Each Reporting Person disclaims beneficial ownership in the securities reported on this Form 4 except to the extent of its or his pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.